ACCORD HEALTHCARE, INC. 2025-07-23 Health serious FDA
Health · FDA · Recall #FDA-D-0518-2025
Levothyroxine Sodium Tablets, USP, 25 mcg (0.025 mg), 90-count bottle, Rx Only,… Recall
Issued July 23, 2025 · ACCORD HEALTHCARE, INC.
In July 2025, ACCORD HEALTHCARE, INC. recalled the Levothyroxine Sodium Tablets, USP, 25 mcg (0.025 mg), 90-count bottle, Rx Only,…, a serious health recall reported by the FDA.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Subpotent Drug: Assay below the approved specification
What you should do
- 1 Stop using Levothyroxine Sodium Tablets, USP, 25 mcg (0.025 mg), 90-count bottle, Rx Only,… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact ACCORD HEALTHCARE, INC. to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- ACCORD HEALTHCARE, INC.
- Category
- Health
- Recall date
- July 23, 2025
- Units affected
- Not reported
- Sold at
- Nationwide in the USA
- Recall number
- FDA-D-0518-2025
- Made in
- United States
- Issuing agency
- FDA
In context
- ACCORD HEALTHCARE, INC. has 6 recalls in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 691st Health recall we've logged in 2025.